Horio Y - Search Results

1

Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence.

Mitsudomi T, Kosaka T, Endoh H, Horio Y, Hida T, Mori S, Hatooka S, Shinoda M, Takahashi T, Yatabe Y. Mitsudomi T, et al. Among authors: horio y. J Clin Oncol. 2005 Apr 10;23(11):2513-20. doi: 10.1200/JCO.2005.00.992. Epub 2005 Feb 28. J Clin Oncol. 2005. PMID: 15738541 Clinical Trial.

2

Characterization of an 800 kb region at 3p22-p21.3 that was homozygously deleted in a lung cancer cell line.

Murata Y, Tamari M, Takahashi T, Horio Y, Hibi K, Yokoyama S, Inazawa J, Yamakawa K, Ogawa A, Takahashi T, et al. Murata Y, et al. Among authors: horio y. Hum Mol Genet. 1994 Aug;3(8):1341-4. doi: 10.1093/hmg/3.8.1341. Hum Mol Genet. 1994. PMID: 7987312

3

Predominantly tumor-limited expression of a mutant allele in a Japanese family carrying a germline p53 mutation.

Horio Y, Suzuki H, Ueda R, Koshikawa T, Sugiura T, Ariyoshi Y, Shimokata K, Takahashi T, Takahashi T. Horio Y, et al. Oncogene. 1994 Apr;9(4):1231-5. Oncogene. 1994. PMID: 8134126

4

Aberrant upregulation of a novel integrin alpha subunit gene at 3p21.3 in small cell lung cancer.

Hibi K, Yamakawa K, Ueda R, Horio Y, Murata Y, Tamari M, Uchida K, Takahashi T, Nakamura Y, Takahashi T. Hibi K, et al. Among authors: horio y. Oncogene. 1994 Feb;9(2):611-9. Oncogene. 1994. PMID: 8290272

5

Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer.

Horio Y, Takahashi T, Kuroishi T, Hibi K, Suyama M, Niimi T, Shimokata K, Yamakawa K, Nakamura Y, Ueda R, et al. Horio Y, et al. Cancer Res. 1993 Jan 1;53(1):1-4. Cancer Res. 1993. PMID: 8380124

6

Frequent homozygous deletions in lung cancer cell lines detected by a DNA marker located at 3p21.3-p22.

Yamakawa K, Takahashi T, Horio Y, Murata Y, Takahashi E, Hibi K, Yokoyama S, Ueda R, Takahashi T, Nakamura Y. Yamakawa K, et al. Among authors: horio y. Oncogene. 1993 Feb;8(2):327-30. Oncogene. 1993. PMID: 8381220

7

Genetic alteration of the beta-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion.

Shigemitsu K, Sekido Y, Usami N, Mori S, Sato M, Horio Y, Hasegawa Y, Bader SA, Gazdar AF, Minna JD, Hida T, Yoshioka H, Imaizumi M, Ueda Y, Takahashi M, Shimokata K. Shigemitsu K, et al. Among authors: horio y. Oncogene. 2001 Jul 12;20(31):4249-57. doi: 10.1038/sj.onc.1204557. Oncogene. 2001. PMID: 11464291

8

Identification of MGB1 as a marker in the differential diagnosis of lung tumors in patients with a history of breast cancer by analysis of publicly available SAGE data.

Koga T, Horio Y, Mitsudomi T, Takahashi T, Yatabe Y. Koga T, et al. Among authors: horio y. J Mol Diagn. 2004 May;6(2):90-5. doi: 10.1016/S1525-1578(10)60495-3. J Mol Diagn. 2004. PMID: 15096563 Free PMC article.

9

Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines.

Osada H, Tatematsu Y, Sugito N, Horio Y, Takahashi T. Osada H, et al. Among authors: horio y. Mol Carcinog. 2005 Dec;44(4):233-41. doi: 10.1002/mc.20135. Mol Carcinog. 2005. PMID: 16163707

10

[Molecular targeted therapy--non-small-cell lung cancer and gefitinib].

Shimizu J, Horio Y, Mitsudomi T. Shimizu J, et al. Among authors: horio y. Gan To Kagaku Ryoho. 2005 Nov;32(12):1879-85. Gan To Kagaku Ryoho. 2005. PMID: 16282720 Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

395 results

Search Page

Filters